Advertisement

Topics

Vedanta Biosciences awarded grant to test treatment of serious bacterial infections

08:55 EST 8 Nov 2017 | EPM Magazine

An affiliate of PureTech Health, Vedanta Biosciences, has been awarded a research grant of up to $5.4 million from Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) to support clinical testing of its lead product

Original Article: Vedanta Biosciences awarded grant to test treatment of serious bacterial infections

NEXT ARTICLE

More From BioPortfolio on "Vedanta Biosciences awarded grant to test treatment of serious bacterial infections"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...